Authors:
SANTOMAGGIO C
PORTALONE L
SEEBACHER C
BAZZICALUPO F
SORESI E
Citation: C. Santomaggio et al., PHASE-I STUDY OF GEMCITABINE AND VINORELBINE IN NONSMALL CELL LUNG-CANCER (NSCLC)-ELDERLY PATIENTS, Annals of oncology, 9, 1998, pp. 136-136
Authors:
BALDINI E
TIBALDI C
ARDIZZONI A
SALVATI F
ANTILLI A
PORTALONE L
BARBERA S
ROMANO F
DEMARINIS F
MIGLIORINO MR
NOSEDA MA
BORGHINI U
CRIPPA M
FERRARA G
RAIMONDI M
FIORETTI M
BANDERA M
PENNUCCI MC
GALEASSO G
CACCIANI GC
LEPIDINI G
SUNSERI G
LANFRANCO C
RINALDI M
LIONETTO R
CONTE PF
ROSSO R
Citation: E. Baldini et al., CISPLATIN-VINDESINE-MITOMYCIN (MVP) VS CISPLATIN-IFOSFAMIDE-VINORELBINE (PIN) VS CARBOPLATIN-VINORELBINE (CAN) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A FONICAP RANDOMIZED PHASE-II STUDY, British Journal of Cancer, 77(12), 1998, pp. 2367-2370
Authors:
PAONE G
DEANGELIS G
GRECO S
PORTALONE L
DEMARCHIS L
GALLUCCIO G
TAGLIENTI A
BISETTI A
AMEGLIO F
Citation: G. Paone et al., EVALUATION OF RESPONSE TO CHEMOTHERAPY IN PATIENTS AFFECTED WITH NONSMALL CELL LUNG-CANCER BY MEANS OF 3 TUMOR-MARKERS ELABORATED BY DISCRIMINANT-ANALYSIS, Respiratory medicine, 91(6), 1997, pp. 361-367
Authors:
PAONE G
DEANGELIS G
PORTALONE L
GRECO S
GIOSUE S
TAGLIENTI A
BISETTI A
AMEGLIO F
Citation: G. Paone et al., VALIDATION OF AN ALGORITHM ABLE TO DIFFERENTIATE SMALL-CELL LUNG-CANCER (SCLC) FROM NON-SMALL-CELL LUNG-CANCER (NSCLC) PATIENTS BY MEANS OFA TUMOR-MARKER PANEL - ANALYSIS OF THE ERRORS, British Journal of Cancer, 75(3), 1997, pp. 448-450
Authors:
BALDINI E
PORTALONE L
DEMARINIS F
BARBERA S
ARDIZZONI A
PENNUCCI MC
RAIMONDI M
CONTE PF
SALVATI F
CAFFERATA MA
SORESI E
PORCILE GF
TESTORE F
RIMOLDI R
BANDERA M
DIROSA T
RINALDI M
LIONETTO R
ROSSO R
Citation: E. Baldini et al., CISPLATIN, VINDESINE, MITOMYCIN (MVP) VS CISPLATIN, IFOSFAMIDE, NAVELBINE (PIN) VS CARBOPLATIN, NAVELBINE (CAN) IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1059-1059
Authors:
SALVATI F
ANTILLI A
CRUCIANI AR
LOMBARDI A
MUGNAINI L
NUNZIATI F
PERRONE N
PORTALONE L
SIGNORA M
Citation: F. Salvati et al., LONIDAMINE PLUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER IN THE ELDERLY - A PHASE-II STUDY, Tumori, 81(1), 1995, pp. 48-51
Authors:
ARDIZZONI A
ADDAMO GF
BALDINI E
BORGHINI U
PORTALONE L
DEMARINIS F
LIONETTO R
CONTE PF
BRUZZI P
PENNUCCI MC
VENTURINI M
RINALDI M
ROSSO R
SALVATI F
Citation: A. Ardizzoni et al., MITOMYCIN-IFOSFAMIDE-CISPLATINUM (MIP) VS MIP-INTERFERON VS CISPLATINUM-CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A FONICAP RANDOMIZED PHASE-II STUDY, British Journal of Cancer, 71(1), 1995, pp. 115-119
Authors:
ARDIZZONI A
SALVATI F
ROSSO R
BRUZZI P
RUBAGOTTI A
PENNUCCI MC
MARIANI GL
DEMARINIS F
PALLOTTA G
ANTILLI A
CRUCIANI AM
RINALDI M
TONACHELLA R
FIORETTI M
BARBERA S
MANTELLINI E
SORESI E
PASTORINO G
BELLI M
FERRARA G
VENTURINI M
SCAGLIOTTI G
SANTI L
PORTALONE L
CRIPPA M
BORGHINI U
BREMA F
RIMOLDI R
BANDERA M
PIACENZA G
ROMANO F
COLANTUONI G
BONSIGNORE G
EPIS R
ANDREOLA E
SCAGLIOTTI E
POZZI E
BOTTA M
CASTAGNETO B
LANFRANCO C
TESTORE F
LUPPIS B
DEPALMA M
ROCCHI D
BARACCO F
CINQUEGRANA A
RASO C
BONAVIA M
ROPOLO F
Citation: A. Ardizzoni et al., COMBINATION OF CHEMOTHERAPY AND RECOMBINANT ALPHA-INTERFERON IN ADVANCED NONSMALL CELL LUNG-CANCER - MULTICENTRIC RANDOMIZED FONICAP TRIAL REPORT, Cancer, 72(10), 1993, pp. 2929-2935